Want to add some dividends to your portfolio in December? Check out Amgen, Gilead Sciences, American Tower, Enterprise Products Partners, and Albemarle Corporation.
November is coming to an end, but it isn’t too late to buy shares of Applied Materials, TSMC, or Qualcomm.
The Soros Fund showed a healthy appetite for biotech stocks in Q3 -- ignoring the political risk.
Here's how to invest.
The Fidelity Select Health Care Fund is a top healthcare fund thanks to bold bets on its favorite stock picks.
Here's why Amgen, Gilead Sciences, and Lilly just might have paid a lower effective tax rate than you did in 2015.
Here's what you need to know about what Amgen's management said in the biotech's Q3 earnings call.
Market potential for Nuplazid and a lower market cap could make ACADIA a prime acquisition target.
Are Intel and InvenSense good contrarian plays on the fledgling VR market?
Here's why AMN Healthcare Services, Air Methods, and AmerisourceBergen look like healthcare bargains.